pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL.

por Adema, G. J., Bakker, A. B., de Boer, A. J., Hohenstein, P., Figdor, C. G.
Publicado 1996

Calcium/NFAT signalling promotes early nephrogenesis

por Burn, S.F., Webb, A., Berry, R.L., Davies, J.A., Ferrer-Vaquer, A., Hadjantonakis, A.K., Hastie, N.D., Hohenstein, P.
Publicado 2011

Human iPSC-derived renal organoids engineered to report oxidative stress can predict drug-induced toxicity

por Lawrence, M.L., Elhendawi, M., Morlock, M., Liu, W., Liu, S., Palakkan, A., Seidl, L.F., Hohenstein, P., Sjögren, A.K., Davies, J.A.
Publicado 2022

Embryonic lethality in the Brca1-1700T mouse model suggests inhibition of p53-dependent pathways

por Hohenstein, P, Kielman, M, Breukel, C, Krimpenfort, P, Berns, A, Bennett, M, Wiseman, R, Cornelisse, C, van Ommen, G-J, Devilee, P, Fodde, R
Publicado 2000